NCT05795335View on ClinicalTrials.gov

CDK4/6 Inhibitors in Patients With Hormone Receptor-positive Advanced Breast Cancer

RecruitingOBSERVATIONAL

Enrollment

172

Participants

Timeline

Start Date

April 30, 2023

Primary Completion Date

April 30, 2026

Study Completion Date

December 30, 2028

Conditions

Breast Cancer

Interventions

DRUG

CDK4/6 inhibitor

CDK4/6 inhibitors

Trial Locations (1)

200127

RECRUITING

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai

All Listed Sponsors

lead

RenJi Hospital

OTHER